Polyphor AG’s License Agreement With Fosun Pharma For Balixafortide In China

Paolo Bossi

VISCHER advised Polyphor AG on all legal issues related to the transaction. Polyphor AG (SIX: POLN) and Shanghai Fosun Pharmaceutical (Group) Co. Ltd (“Fosun Pharma”, stock…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here